Characterization of tumor heterogeneity using dynamic contrast enhanced CT and FDG-PET in non-small cell lung cancer

Radiotherapy and Oncology

Volumn 109, Issue 1, 2013, Pages 65-70

  Van Elmpt, Wouter ^a   Das, Marco ^a   Hüllner, Martin ^b   Sharifi, Hoda ^a   Zegers, Catharina M L ^a   Reymen, Bart ^a   Lambin, Philippe ^a   Wildberger, Joachim E ^a   Troost, Esther G C ^a   Veit Haibach, Patrick ^b   De Ruysscher, Dirk ^a,c  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Dynamic contrast enhanced (dce) ct; Fdg pet; Image analysis; Nsclc; Perfusion ct imaging

Indexed keywords

FLUORODEOXYGLUCOSE; IOPROMIDE;

ALGORITHM; ARTICLE; BLOOD FLOW; BLOOD VOLUME; CANCER DIAGNOSIS; CANCER PATIENT; CLINICAL ARTICLE; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED EMISSION TOMOGRAPHY; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; CORRELATION ANALYSIS; DYNAMIC CONTRAST ENHANCED COMPUTER ASSISTED TOMOGRAPHY; HUMAN; IMAGING SOFTWARE; LUNG NON SMALL CELL CANCER; LUNG PERFUSION; PERMEABILITY; PET SCANNER; PRIORITY JOURNAL; TUMOR BLOOD FLOW; TUMOR VASCULARIZATION; TUMOR VOLUME;

DYNAMIC CONTRAST ENHANCED (DCE) CT; FDG-PET; IMAGE ANALYSIS; NSCLC; PERFUSION CT IMAGING;

CARCINOMA, NON-SMALL-CELL LUNG; FLUORODEOXYGLUCOSE F18; LUNG NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; RADIOGRAPHIC IMAGE ENHANCEMENT; RADIOPHARMACEUTICALS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84888067554     PISSN: 01678140     EISSN: 18790887     Source Type: Journal    
DOI: 10.1016/j.radonc.2013.08.032     Document Type: Article

References (34)

1. P. Carmeliet, and R.K. Jain Molecular mechanisms and clinical applications of angiogenesis Nature 473 2011 298 307
2. W.R. Wilson, and M.P. Hay Targeting hypoxia in cancer therapy Nat Rev Cancer 11 2011 393 410
3. D. De Ruysscher, and C.M. Kirsch PET scans in radiotherapy planning of lung cancer Radiother Oncol 96 2010 335 338
4. M. MacManus, U. Nestle, and K.E. Rosenzweig Use of PET and PET/CT for radiation therapy planning: IAEA expert report 2006-2007 Radiother Oncol 91 2009 85 94
5. A. van Baardwijk, C. Dooms, and R.J. van Suylen The maximum uptake of (18)F-deoxyglucose on positron emission tomography scan correlates with survival, hypoxia inducible factor-1alpha and GLUT-1 in non-small cell lung cancer Eur J Cancer 43 2007 1392 1398
6. V. Goh, Q.S. Ng, and K. Miles Computed tomography perfusion imaging for therapeutic assessment: has it come of age as a biomarker in oncology? Invest Radiol 47 2012 2 4
7. R. Garcia-Figueiras, V.J. Goh, and A.R. Padhani CT perfusion in oncologic imaging: a useful tool? AJR Am J Roentgenol 200 2013 8 19
8. C.S. Ng, A.G. Chandler, and W. Wei Reproducibility of perfusion parameters obtained from perfusion CT in lung tumors AJR Am J Roentgenol 197 2011 113 121
9. N. Tacelli, M. Remy-Jardin, and M.C. Copin Assessment of non-small cell lung cancer perfusion: pathologic-CT correlation in 15 patients Radiology 257 2010 863 871
10. 18F-FDG PET/CT and volume perfusion CT J Nucl Med 53 2012 521 529
11. Y. Li, Z.G. Yang, T.W. Chen, H.J. Chen, and J.Y.Lu.Y.R. Sun Peripheral lung carcinoma: correlation of angiogenesis and first-pass perfusion parameters of 64-detector row CT Lung Cancer 61 2008 44 53
12. H.C. Mandeville, Q.S. Ng, and F.M. Daley Operable non-small cell lung cancer: correlation of volumetric helical dynamic contrast-enhanced CT parameters with immunohistochemical markers of tumor hypoxia Radiology 264 2012 581 589
13. 2O PET in lung tumors: effects of CT-perfusion methodology Med Phys 40 2013 052502
14. A. Abramyuk, S. Tokalov, and K. Zophel Is pre-therapeutical FDG-PET/CT capable to detect high risk tumor subvolumes responsible for local failure in non-small cell lung cancer? Radiother Oncol 91 2009 399 404
15. H.J. Aerts, A.A. van Baardwijk, and S.F. Petit Identification of residual metabolic-active areas within individual NSCLC tumours using a pre-radiotherapy (18)fluorodeoxyglucose-PET-CT scan Radiother Oncol 91 2009 386 392
16. S.F. Petit, H.J. Aerts, and J.G. van Loon Metabolic control probability in tumour subvolumes or how to guide tumour dose redistribution in non-small cell lung cancer (NSCLC): an exploratory clinical study Radiother Oncol 91 2009 393 398
17. A.E. Hansen, A.T. Kristensen, I. Law, F.J. McEvoy, A. Kjaer, and S.A. Engelholm Multimodality functional imaging of spontaneous canine tumors using 64Cu-ATSM and 18FDG PET/CT and dynamic contrast enhanced perfusion CT Radiother Oncol 102 2012 424 428
18. Y. Ohno, H. Koyama, and K. Matsumoto Differentiation of malignant and benign pulmonary nodules with quantitative first-pass 320-detector row perfusion CT versus FDG PET/CT Radiology 258 2011 599 609
19. 18FDG/PET-CT studies in lung cancer patients: clinical staging and functional information in a single study Eur J Nucl Med Mol Imaging 40 2013 156 165
20. A.W. Sauter, D. Spira, and M. Schulze Correlation between [(18)F]FDG PET/CT and volume perfusion CT in primary tumours and mediastinal lymph nodes of non-small-cell lung cancer Eur J Nucl Med Mol Imaging 40 2013 677 684
21. K.S. Lazanyi, A. Abramyuk, and G. Wolf Usefulness of dynamic contrast enhanced computed tomography in patients with non-small-cell lung cancer scheduled for radiation therapy Lung Cancer 70 2010 280 285
22. K.A. Miles, M.R. Griffiths, and C.J. Keith Blood flow-metabolic relationships are dependent on tumour size in non-small cell lung cancer: a study using quantitative contrast-enhanced computer tomography and positron emission tomography Eur J Nucl Med Mol Imaging 33 2006 22 28
23. P. Lambin, S.F. Petit, H.J. Aerts The E.S.T.R.O. Breur Lecture From population to voxel-based radiotherapy: exploiting intra-tumour and intra-organ heterogeneity for advanced treatment of non-small cell lung cancer Radiother Oncol 2010 2009 145 152
24. P. Lambin, R.G. van Stiphout, and M.H. Starmans Predicting outcomes in radiation oncology-multifactorial decision support systems Nat Rev Clin Oncol 10 2013 27 40
25. R. Hermans, P. Lambin, and A. Van der Goten Tumoural perfusion as measured by dynamic computed tomography in head and neck carcinoma Radiother Oncol 53 1999 105 111
26. J. Wang, N. Wu, M.D. Cham, and Y. Song Tumor response in patients with advanced non-small cell lung cancer: perfusion CT evaluation of chemotherapy and radiation therapy AJR Am J Roentgenol 193 2009 1090 1096
27. Q.S. Ng, V. Goh, J. Milner, A.R. Padhani, M.I. Saunders, and P.J. Hoskin Acute tumor vascular effects following fractionated radiotherapy in human lung cancer: in vivo whole tumor assessment using volumetric perfusion computed tomography Int J Radiat Oncol Biol Phys 67 2007 417 424
28. W. van Elmpt, D. De Ruysscher, and A. van der Salm The PET-boost randomised phase II dose-escalation trial in non-small cell lung cancer Radiother Oncol 104 2012 67 71
29. J. Orban de Xivry, G. Janssens, and G. Bosmans Tumour delineation and cumulative dose computation in radiotherapy based on deformable registration of respiratory correlated CT images of lung cancer patients Radiother Oncol 85 2007 232 238
30. A.J. de Langen, V. van den Boogaart, and M. Lubberink Monitoring response to antiangiogenic therapy in non-small cell lung cancer using imaging markers derived from PET and dynamic contrast-enhanced MRI J Nucl Med 52 2011 48 55
31. Y. Ren, D. Fleischmann, and K. Foygel Antiangiogenic and radiation therapy: early effects on in vivo computed tomography perfusion parameters in human colon cancer xenografts in mice Invest Radiol 47 2012 25 32
32. V. Goh, M. Shastry, and A. Engledow Commercial software upgrades may significantly alter perfusion CT parameter values in colorectal cancer Eur Radiol 21 2011 744 749
33. T.S. Koh, Q.S. Ng, C.H. Thng, J.W. Kwek, R. Kozarski, and V. Goh Primary colorectal cancer: use of kinetic modeling of dynamic contrast-enhanced CT data to predict clinical outcome Radiology 267 2013 145 154
34. J.G. Korporaal, M. van Vulpen, C.A. van den Berg, and U.A. van der Heide Tracer kinetic model selection for dynamic contrast-enhanced computed tomography imaging of prostate cancer Invest Radiol 47 2012 41 48